Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study

As it has been shown that lopinavir (LPV) and hydroxychloroquine (HCQ) have in vitro activity against coronaviruses, they were used to treat COVID‐19 during the first wave of the epidemic in Lombardy, Italy. To compare the rate of clinical improvement between those who started LPV/ritonavir (LPV/r)+...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Virol
Hlavní autoři: Giacomelli, Andrea, Pagani, Gabriele, Ridolfo, Anna L., Oreni, Letizia, Conti, Federico, Pezzati, Laura, Bradanini, Lucia, Casalini, Giacomo, Bassoli, Cinzia, Morena, Valentina, Passerini, Simone, Rizzardini, Giuliano, Cogliati, Chiara, Ceriani, Elisa, Colombo, Riccardo, Rusconi, Stefano, Gervasoni, Cristina, Cattaneo, Dario, Antinori, Spinello, Galli, Massimo
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436522/
https://ncbi.nlm.nih.gov/pubmed/32776534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26407
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky